Cargando…

P1085: HISTOLOGICAL TRANSFORMATION OF FOLLICULAR LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA WITHIN 48 MONTHS (TOD48) INDICATING AN ADVERSE PROGNOSIS: EVIDENCE FROM TWO POPULATION-BASED COHORTS

Detalles Bibliográficos
Autores principales: Zihua, LI, Zhang, Minyue, Hou, Jian, Huang, Hong-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431120/
http://dx.doi.org/10.1097/01.HS9.0000971236.88388.5a
_version_ 1785091124680982528
author Zihua, LI
Zhang, Minyue
Hou, Jian
Huang, Hong-Hui
author_facet Zihua, LI
Zhang, Minyue
Hou, Jian
Huang, Hong-Hui
author_sort Zihua, LI
collection PubMed
description
format Online
Article
Text
id pubmed-10431120
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104311202023-08-17 P1085: HISTOLOGICAL TRANSFORMATION OF FOLLICULAR LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA WITHIN 48 MONTHS (TOD48) INDICATING AN ADVERSE PROGNOSIS: EVIDENCE FROM TWO POPULATION-BASED COHORTS Zihua, LI Zhang, Minyue Hou, Jian Huang, Hong-Hui Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431120/ http://dx.doi.org/10.1097/01.HS9.0000971236.88388.5a Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Zihua, LI
Zhang, Minyue
Hou, Jian
Huang, Hong-Hui
P1085: HISTOLOGICAL TRANSFORMATION OF FOLLICULAR LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA WITHIN 48 MONTHS (TOD48) INDICATING AN ADVERSE PROGNOSIS: EVIDENCE FROM TWO POPULATION-BASED COHORTS
title P1085: HISTOLOGICAL TRANSFORMATION OF FOLLICULAR LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA WITHIN 48 MONTHS (TOD48) INDICATING AN ADVERSE PROGNOSIS: EVIDENCE FROM TWO POPULATION-BASED COHORTS
title_full P1085: HISTOLOGICAL TRANSFORMATION OF FOLLICULAR LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA WITHIN 48 MONTHS (TOD48) INDICATING AN ADVERSE PROGNOSIS: EVIDENCE FROM TWO POPULATION-BASED COHORTS
title_fullStr P1085: HISTOLOGICAL TRANSFORMATION OF FOLLICULAR LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA WITHIN 48 MONTHS (TOD48) INDICATING AN ADVERSE PROGNOSIS: EVIDENCE FROM TWO POPULATION-BASED COHORTS
title_full_unstemmed P1085: HISTOLOGICAL TRANSFORMATION OF FOLLICULAR LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA WITHIN 48 MONTHS (TOD48) INDICATING AN ADVERSE PROGNOSIS: EVIDENCE FROM TWO POPULATION-BASED COHORTS
title_short P1085: HISTOLOGICAL TRANSFORMATION OF FOLLICULAR LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA WITHIN 48 MONTHS (TOD48) INDICATING AN ADVERSE PROGNOSIS: EVIDENCE FROM TWO POPULATION-BASED COHORTS
title_sort p1085: histological transformation of follicular lymphoma to diffuse large b-cell lymphoma within 48 months (tod48) indicating an adverse prognosis: evidence from two population-based cohorts
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431120/
http://dx.doi.org/10.1097/01.HS9.0000971236.88388.5a
work_keys_str_mv AT zihuali p1085histologicaltransformationoffollicularlymphomatodiffuselargebcelllymphomawithin48monthstod48indicatinganadverseprognosisevidencefromtwopopulationbasedcohorts
AT zhangminyue p1085histologicaltransformationoffollicularlymphomatodiffuselargebcelllymphomawithin48monthstod48indicatinganadverseprognosisevidencefromtwopopulationbasedcohorts
AT houjian p1085histologicaltransformationoffollicularlymphomatodiffuselargebcelllymphomawithin48monthstod48indicatinganadverseprognosisevidencefromtwopopulationbasedcohorts
AT huanghonghui p1085histologicaltransformationoffollicularlymphomatodiffuselargebcelllymphomawithin48monthstod48indicatinganadverseprognosisevidencefromtwopopulationbasedcohorts